Muscone Ameliorates Synaptic Dysfunction and Cognitive Deficits in APP/PS1 Mice

Yi Liu1,2, Huijie Bian1,2,3, Siyi Xu1,2,4

  • 1Department of Neurology, Drum Tower Hospital, Medical School and The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, Nanjing, China.

Abstract

Insights

Muscone improved memory and synaptic plasticity in Alzheimer's disease models by reducing amyloid-beta and enhancing protein degradation. This suggests Muscone is a promising therapeutic candidate for Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Synaptic plasticity dysfunction is a key factor in Alzheimer's disease (AD) related memory impairment.
  • Muscone (Mus) demonstrates neuroprotective properties in cerebral ischemia, but its role in AD is largely unexplored.

Purpose of the Study:

  • To evaluate the impact of Muscone on memory and synaptic plasticity in a mouse model of Alzheimer's disease (APP/PS1 mice).
  • To elucidate the underlying molecular mechanisms of Muscone's effects in AD.

Main Methods:

  • Cognitive function was assessed using Novel Object Recognition and Morris Water Maze tests.
  • Amyloid-beta (Aβ) levels, synaptic morphology, and plasticity were quantified.
  • Histone deacetylase 2 (HDAC2) levels, ubiquitination, and interactions were analyzed using biochemical and computational methods.

Main Results:

  • Muscone treatment significantly improved memory deficits and enhanced synaptic plasticity in APP/PS1 mice.
  • Muscone reduced amyloid-beta levels and decreased HDAC2 expression in the hippocampus.
  • Increased HDAC2 ubiquitination, potentially mediated by Muscone interaction, was observed.

Conclusions:

  • Muscone demonstrates therapeutic potential for Alzheimer's disease by mitigating memory impairment and synaptic dysfunction.
  • The mechanism involves HDAC2 degradation via ubiquitination, highlighting a novel therapeutic pathway.

Related Concept Videos